Earnings Feed
Start Free
NYMOX PHARMACEUTICAL CORP·4

Nov 6, 5:26 PM ET

Averback Paul 4

4 · NYMOX PHARMACEUTICAL CORP · Filed Nov 6, 2018

Insider Transaction Report

Form 4
Period: 2018-10-29
NYMOX PHARMACEUTICAL CORPNYMX
Averback Paul
DirectorCEO10% Owner
Transactions
  • Sale

    Restricted common

    2018-10-29$2.50/sh−1,687,600$4,219,000→ 21,643,948 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT